Suchbegriffe: OSTEOPOROSIS, POSTMENOPAUSAL - BLOOD , . Treffer: 4
Kocijan, R; Muschitz, C; Geiger, E; Skalicky, S; Baierl, A; Dormann, R; Plachel, F; Feichtinger, X; Heimel, P; Fahrleitner-Pammer, A; Grillari, J; Redl, H; Resch, H; Hackl, M
Circulating microRNA Signatures in Patients With Idiopathic and Postmenopausal Osteoporosis and Fragility Fractures.
J Clin Endocrinol Metab. 2016; 101(11):4125-4134
Doi: 10.1210/jc.2016-2365
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Roux, C; Hofbauer, LC; Ho, PR; Wark, JD; Zillikens, MC; Fahrleitner-Pammer, A; Hawkins, F; Micaelo, M; Minisola, S; Papaioannou, N; Stone, M; Ferreira, I; Siddhanti, S; Wagman, RB; Brown, JP
Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.
Bone. 2014; 58(2):48-54
Doi: 10.1016/j.bone.2013.10.006
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Satterwhite, J; Heathman, M; Miller, PD; Marín, F; Glass, EV; Dobnig, H
Pharmacokinetics of teriparatide (rhPTH[1-34]) and calcium pharmacodynamics in postmenopausal women with osteoporosis.
Calcif Tissue Int. 2010; 87(6):485-492
Doi: 10.1007/s00223-010-9424-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fahrleitner-Pammer, A; Dobnig, H; Piswanger-Soelkner, C; Bonelli, C; Dimai, HP; Leb, G; Obermayer-Pietsch, B
Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status.
Wien Klin Wochenschr. 2003; 115(9):291-297
Doi: 10.1007/BF03040334
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar